- decreased circulating LDL cholesterol level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased circulating calcium level / IMPC
- decreased circulating glycerol level / IMPC
- decreased circulating iron level / IMPC
- decreased circulating cholesterol level / IMPC
- increased circulating aspartate transaminase level / IMPC
- thrombocytosis / IMPC
- decreased circulating total protein level / IMPC
- increased circulating amylase level / IMPC
C57BL/6N-Sidt2em1(IMPC)Wtsi/WtsiH
Status | Available to order |
EMMA ID | EM:13877 |
Citation information | RRID:IMSR_EM:13877 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6N-Sidt2em1(IMPC)Wtsi/WtsiH |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Sidt2em1(IMPC)Wtsi |
Gene/Transgene symbol | Sidt2 |
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased circulating amylase level / IMPC
- decreased circulating calcium level / IMPC
- decreased circulating iron level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased circulating total protein level / IMPC
- decreased circulating glycerol level / IMPC
- increased circulating aspartate transaminase level / IMPC
- decreased circulating cholesterol level / IMPC
- thrombocytosis / IMPC
- decreased circulating LDL cholesterol level / IMPC
MGI phenotypes (gene matching)
- abnormal liver morphology / MGI
- abnormal hepatocyte morphology / MGI
- decreased body weight / MGI
- decreased body size / MGI
- increased circulating triglyceride level / MGI
- hepatic necrosis / MGI
- liver inflammation / MGI
- no abnormal phenotype detected / MGI
- hepatic steatosis / MGI
- decreased circulating insulin level / MGI
- increased circulating alanine transaminase level / MGI
- liver fibrosis / MGI
- abnormal insulin secretion / MGI
- increased pancreatic beta cell number / MGI
- abnormal pancreatic beta cell morphology / MGI
- impaired glucose tolerance / MGI
- increased circulating aspartate transaminase level / MGI
- homeostasis/metabolism phenotype / MGI
- increased circulating glucose level / MGI
- increased liver triglyceride level / MGI
- abnormal endoplasmic reticulum morphology / MGI
- increased liver free fatty acids level / MGI
- increased endoplasmic reticulum stress / MGI